🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOrforglipron Phase 3 ATTAIN-1 topline — anyone have experience? Page 5

Orforglipron Phase 3 ATTAIN-1 topline — anyone have experience?

steve_okc Wed, Jan 29, 2025 at 11:16 AM 30 replies 1,800 viewsPage 5 of 6
maria_elpaso
Member
312
1,456
Sep 2024
El Paso, TX
Jan 29, 2025 at 6:21 PM#21

Congrats steve_okc!! Keep going — you're doing incredible. 🎉

9 7FitDadDave, RunnerRach, TrialNerd_Beth and 6 others
Reply Quote Save Share Report
GraceAZ_72
Member
156
678
Jan 2025
Tucson, AZ
Jan 29, 2025 at 6:38 PM#22

Reading this thread on Orforglipron Phase 3 hits close to home. Night shift nurse — I started at 263 lbs and felt like I would tried everything.

9 months on tirz and I am a different person. Not just the 38 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Orforglipron Phase 3 — take the leap. It was the best health decision I have ever made. ❤️

Last edited: Jan 29, 2025 at 10:38 PM
23 14CryptoCarl, MariaRD, AussieAnna and 20 others
Reply Quote Save Share Report
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Jan 29, 2025 at 6:55 PM#23

As a pharmacist, I want to add some clinical context to this discussion on Orforglipron Phase 3 ATTAIN-1 topline .

Building on what maria_elpaso said — the evidence base here is robust. The key publications to reference are from the FLOW program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Jan 29, 2025 at 9:55 PM
12 3PharmHunterJen, TomTeleRx, DoseLogDan and 9 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.EndoEP
Member
267
1,234
Oct 2024
El Paso, TX
Jan 29, 2025 at 7:12 PM#24

GraceAZ_72 — wow. I've been looking for this exact info for weeks.

2 15Dr.BariatricHTX, LindaRN_retired
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Jan 29, 2025 at 7:29 PM#25

Adding my data to this Orforglipron Phase 3 discussion:

MetricBaselineMonth 5Month 6
Weight256 lbs226 lbs221 lbs
A1C7.0%6.0%5.2%
hsCRP5.04.00.6

Protocol: Semaglutide 1.7mg/wk, resistance training 3x/wk, protein 1.3g/kg/day.

5 5LabKate, kate.chem, DataDave and 2 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register